Other atai Life Sciences Announces First Subject Dosed in Phase 1 Trial of Buccal and IV VLS-01, a Synthetic Form of DMT October 5, 2022
Other Seelos Therapeutics to Participate in the Guggenheim Nantucket Therapeutics Conference September 9, 2022
Other Red Light Holland Announces Live Investor Q&A Session at 2:00 PM (EST) on Thursday, September 8, 2022 September 2, 2022
Other MindMed Announces First Patient Dosed in Phase 2b Trial of MM-120 in Generalized Anxiety Disorder August 25, 2022
Other Seelos Therapeutics Receives a Research and Development Grant from The Michael J. Fox Foundation for Parkinson’s Research for SLS-004 August 24, 2022
Other Healthy Extracts Reports Record Second Quarter 2022, Net Revenue up 93% with Strong Subscription-Based Revenue Growth August 15, 2022
Search
Other
October 5, 2022
September 14, 2022
September 9, 2022
September 6, 2022
September 2, 2022
August 30, 2022
August 29, 2022
August 25, 2022
August 24, 2022
August 15, 2022
